IHC 2021 | Progress In Mind

Home

The Progress in Mind Resource Center brings you the latest research from this years International Headache Congress 2021

The Progress in Mind Resource Center is pleased to bring you highlights from IHC 2021, held virtually from September 8-12, 2021.

Stay tuned as our medical writers develop articles highlighting many of the very interesting symposia and other lectures from IHC 2021.

Read time: 3 min

Congress highlights

The omics and migraine

The omics — genomics, epigenomics, pharmacogenomics, proteomics and metabolomics — are...

Read time: 2 min

Congress highlights

What is the relationship between acute medication use and medication-overuse headache?

The term medication-overuse headache implies headache caused by overuse of medication, but overuse...

Read time: 2 min

Congress highlights

New insights from a poster at IHC2021 on how patients respond when switched from one anti-CGRP monoclonal antibody to another

What is the effect of switching to a second anti-CGRP monoclonal antibody when migraine fails to...

Read time: 3 min

Congress highlights

New insights from posters at IHC2021 on how COVID-19 tests and lockdowns have affected patients with migraine

Does a nasopharyngeal swab for COVID-19 trigger migraine and what has been the impact of COVID-19...

Read time: 2 min

Congress highlights

New insights from a poster at IHC2021 on the depiction of migraine in the media

How realistic is the presentation of migraine in the media? Does it help raise awareness and lessen...

Read time: 2 min

Congress highlights

New insights from posters at IHC2021 — migraine and body mass index and the everyday burden of migraine

What is the relationship between high body mass index and migraine? and What is the real-world...

Read time: 3 min

Congress highlights

Do anti-CGRP monoclonal antibodies alter the expected course of migraine?

Are anti-CGRP monoclonal antibodies disease modifying therapies for migraine? Do they alter the...

Read time: 3 min

Congress highlights

Do anti-CGRP monoclonal antibodies alter the expected course of migraine?

Are anti-CGRP monoclonal antibodies disease modifying therapies for migraine? Do they alter the...

Read time: 2 min

Satellite symposium

Anti-CGRP monoclonal antibodies in the real world

When are anti-CGRP monoclonal antibodies used for migraine in the real world, how effective are...

Read time: 2 min

Congress highlights

Is precision medicine possible in migraine?

Is precision medicine possible in migraine? This was the subject of an entertaining debate at...

Read time: 3 min

Satellite symposium

Expert insights into medication overuse headache

Medication overuse headache is common, but much is still not clear about its precise prevalence...

Other conferences

Read time: Read time: 1 min

Read time: Read time: 1 min

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline